These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 29540832

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
    Wu Q, Zhao Y, Sun Y, Yan X, Wang P.
    Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
    [Abstract] [Full Text] [Related]

  • 3. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W, Liu Y, Yan Z, Yang H, Sun W, Yao Y, Chen Y, Jiang R.
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [Abstract] [Full Text] [Related]

  • 4. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
    Gray MJ, Gong J, Hatch MM, Nguyen V, Hughes CC, Hutchins JT, Freimark BD.
    Breast Cancer Res; 2016 May 11; 18(1):50. PubMed ID: 27169467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling.
    Xia W, Zou C, Chen H, Xie C, Hou M.
    Cell Death Dis; 2020 Jul 24; 11(7):575. PubMed ID: 32709878
    [Abstract] [Full Text] [Related]

  • 8. The role of the PD-1/PD-L1 axis in macrophage differentiation and function during pregnancy.
    Zhang Y, Ma L, Hu X, Ji J, Mor G, Liao A.
    Hum Reprod; 2019 Jan 01; 34(1):25-36. PubMed ID: 30500923
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-146a Controls Immune Response in the Melanoma Microenvironment.
    Mastroianni J, Stickel N, Andrlova H, Hanke K, Melchinger W, Duquesne S, Schmidt D, Falk M, Andrieux G, Pfeifer D, Dierbach H, Schmitt-Graeff A, Meiss F, Boerries M, Zeiser R.
    Cancer Res; 2019 Jan 01; 79(1):183-195. PubMed ID: 30425059
    [Abstract] [Full Text] [Related]

  • 11. Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
    Dhupkar P, Gordon N, Stewart J, Kleinerman ES.
    Cancer Med; 2018 Jun 01; 7(6):2654-2664. PubMed ID: 29733528
    [Abstract] [Full Text] [Related]

  • 12. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.
    He S, Song W, Cui S, Li J, Jiang Y, Chen X, Peng L.
    Cell Oncol (Dordr); 2023 Dec 01; 46(6):1731-1746. PubMed ID: 37402945
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
    Xu P, Xiong W, Lin Y, Fan L, Pan H, Li Y.
    Cell Death Dis; 2021 Aug 07; 12(8):779. PubMed ID: 34365463
    [Abstract] [Full Text] [Related]

  • 14. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis.
    Wang Q, Li G, Ma X, Liu L, Liu J, Yin Y, Li H, Chen Y, Zhang X, Zhang L, Sun L, Ai J, Xu S.
    Cell Death Dis; 2023 Feb 01; 14(2):76. PubMed ID: 36725842
    [Abstract] [Full Text] [Related]

  • 15. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X, Zeng Y, Qu Q, Zhu J, Liu Z, Ning W, Zeng H, Zhang N, Du W, Chen C, Huang JA.
    Int J Clin Oncol; 2017 Dec 01; 22(6):1026-1033. PubMed ID: 28748356
    [Abstract] [Full Text] [Related]

  • 16. [Paeonol inhibits macrophage M1 polarization by down-regulating miR-155/JAK1-STAT1 pathway].
    Sun Y, Liu L, Shi XY, He H, Huang HW, Dai M.
    Zhongguo Zhong Yao Za Zhi; 2020 May 01; 45(9):2158-2164. PubMed ID: 32495566
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan.
    Chen W, Wang J, Jia L, Liu J, Tian Y.
    Cell Death Dis; 2016 Feb 25; 7(2):e2115. PubMed ID: 26913605
    [Abstract] [Full Text] [Related]

  • 18. JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Chen M, Pockaj B, Andreozzi M, Barrett MT, Krishna S, Eaton S, Niu R, Anderson KS.
    Clin Breast Cancer; 2018 Oct 25; 18(5):e1205-e1215. PubMed ID: 29933930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-150 deficiency accelerates intimal hyperplasia by acting as a novel regulator of macrophage polarization.
    Qiu M, Ma J, Zhang J, Guo X, Liu Q, Yang Z.
    Life Sci; 2020 Jan 01; 240():116985. PubMed ID: 31647949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.